Skip to main content
Clinical Trials/NCT03568253
NCT03568253TerminatedNot Applicable

Longitudinal Follow-up of High Viscosity Glassionomer IonoStar Plus Versus a Composite Bulk X-tra-Fil Combined With Futurabond U (Splith Mouth Study)

University Hospital, Montpellier1 site in 1 country65 target enrollmentStarted: September 21, 2018Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Terminated
Enrollment
65
Locations
1
Primary Endpoint
Evaluation of the International Dental Federation Score

Study Overview

Brief Summary

The main objective is the longitudinal follow-up and comparison of the maintenance of the dental filling materials up to 24 months using the HVGIC IonoStar Plus versus Bulk X-Tra -Fil composite (Futurabond U adhesive system). 150 patients will be recruited in the Mafate dental health center. Patients with minimum 2 carious lesions (or multiple of 2, maximum 6) class I or II moderate not including the cusps, and touching the outside part of the middle of dentin. Assignment period will be 4 years: Inclusion period 18 months with 2 years following (6-month, 1 year and 2 years checking) and 3 months for statistical analysis and publications process Estimation of the parameters associated with a failure of the restoration at 24 months will follow the FDI scores. The Secondary objectives are to evaluate the caries risk of isolated population thanks to Cambra application and estimate the concordance of the judgment of maintaining the restoration between the expert in-situ and experts based on the images remotely.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 70 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Patient with 2 carious lesions (or multiple of 2) class I or II moderate not including the cusps, and touching the outside part of the middle of dentin
  • •Asymptomatic tooth or with a reversible pulp syndrome tooth
  • •Measured by pulp test (if not possible should not prevent the inclusion)
  • •Patient consultant in investigative testing center
  • •Patient of 18 to 70 years old
  • •Patient able to support care
  • •Patient able to understand care (no language barrier)
  • •Collect the informed consent signed after a period of reflection
  • •Be affiliated to a French social security scheme or recipient of such a regime
  • •Tooth with criteria for pulp vitality tests of pulp sensibility

Exclusion Criteria

  • •Patient under guardianship
  • •Pregnant or breastfeeding
  • •Patient at risk for infectious endocarditis
  • •Patient with severe periodontal disease (Pocket depth ≥ 5mm and/or mobility IV)
  • •Patient with an allergy to one of the materials used in the study
  • •Patient with an allergy to local anesthesia
  • •Patient with risks of infectious endocarditis
  • •Non-cooperative patient
  • •Participate in another ongoing biomedical research

Arms & Interventions

Bulk fil composite

Active Comparator

Intervention: Caries treatment (Other)

High viscosity glass ionomer

Active Comparator

Intervention: Caries treatment (Other)

Outcomes

Primary Outcomes

Evaluation of the International Dental Federation Score

Time Frame: Change from Baseline Score FDI at 2 years

Score are numbered from 1 to 5 in ascending order of severity for aesthetic criteria (5 items), functional criteria (9 items) and biological criteria (6 items). The score will be used by the practionner making the restoration and by the remote expert to check the results and validate tele-dentistry evaluation.

Secondary Outcomes

  • Validation of the caries risk assememt.(Change from Baseline caries risk assement at 2 years)
  • The carious presence according to the ICDAS / ICCMS criteria using the Soprolife® camera(At each follow-up visit (T0, T6 months, T1year and T2years))

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials